This image shows cultured human cells called fibroblasts in purple, infected with a kind of parasite called Toxoplasma gondii. #microscopy 🧪🔬 Image credit: @simon-butterworth.bsky.social
Hayley Colton
@xhayles.bsky.social
Infectious Diseases/Virology Registrar 🩺💉🧫🧬😷 Admirer of good food and the great outdoors 🗻🌄
Eight additional infectious diseases will be added to the list of notifiable diseases in England once new legislation comes into force on 6 April 2025. Most with the exception of chickenpox will be rare. For more details, see link. www.gov.uk/government/c...
1/ 🎉 Thrilled to share our new study: Quantifying the impact of pre-vaccination titre and vaccination history on influenza vaccine immunogenicity 🦠💉 Published in Vaccine! link: authors.elsevier.com/a/1kD7x,60n7... with @adamjkucharski.bsky.social
authors.elsevier.com
HIV-1 has, for decades, been called, well, HIV-1. But no, according to the ICTV, that will no longer do, so the new name for this virus is "Lentivirus humimdef1". Yup, you read that right. Somebody needs to take away whatever drugs the committee is on. All viruses renamed - it's insane.
Orthohantavirus sinnombreense Mammarenavirus lassaense Mammarenavirus juninense Mammarenavirus lujoense Orthoebolavirus zairense Orthoflavivirus zikaense Orthoflavivirus denguei Orthoflavivirus nilense Henipavirus nipahense Phlebovirus riftense You just can't make this s*** up. You really can't.
The DRC 🇨🇩 is reporting an epidemic caused by an "unknown disease" with people exhibiting flu-like symptoms, first reported by local media, now spread by Reuters, AP etc. There are reports of 143 deaths, with an anonymous source stating that WHO is involved in the investigation.
💉 How do we optimise the neutralising antibody responses of HSCT/CAR-T recipients following COVID vaccination? We found ChAdOx1-S recipients were EIGHT times more likely to have neutralising antibodies than those receiving mRNA vaccines in our new paper! Read more --> doi.org/10.1111/bjh....
Greater preservation of SARS‐CoV‐2 neutralising antibody responses following the ChAdOx1‐S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients
Knowledge of factors impacting immune responses after COVID-19 vaccination is essential for guiding revaccination strategies in haematopoietic stem cell transplant (HSCT) and chimeric antigen recepto...
doi.org